[Form 4] EverQuote, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Jayme Mendal, CEO and President of EverQuote, Inc. (EVER), reported an insider sale on Form 4 conducted under a pre-established Rule 10b5-1 trading plan. On 08/20/2025 Mendal sold 14,360 shares of Class A common stock at a weighted average price of $22.86, with reported sale prices ranging from $22.68 to $23.02. After the transaction Mendal beneficially owned 512,780 shares. The Form 4 was signed by an attorney-in-fact on 08/22/2025. The filing notes the 10b5-1 plan was adopted on December 17, 2024 and that the reported price is a weighted average from multiple trades.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider sold a small portion of holdings under a documented 10b5-1 plan; transaction appears procedural rather than transformational.
The sale of 14,360 shares reduces beneficial ownership to 512,780 shares. The transaction was executed pursuant to a Rule 10b5-1 trading plan adopted December 17, 2024, which provides an affirmative defense for preplanned sales and limits signaling risk. The weighted average price reported is $22.86, with trade prices between $22.68 and $23.02. Given the sale size relative to total reported holdings (approximate single-digit percentage) and the existence of a 10b5-1 plan, the immediate market impact is likely limited. No derivatives, option exercises, or new compensatory grants are disclosed in this filing.
TL;DR: The filing shows compliance with insider-trading protocols via a 10b5-1 plan and standard reporting; governance procedures appear followed.
The Form 4 identifies the reporting person as both CEO and a director and discloses the sale was made under a 10b5-1 plan adopted December 17, 2024, demonstrating use of an established trading mechanism for insiders. Signature by an attorney-in-fact and the explanatory note about weighted-average pricing are consistent with routine SEC reporting practices. The filing does not disclose any amendments, derivative transactions, or changes in officer/director status. From a governance perspective this is a routine compliance disclosure rather than an indicator of adverse corporate events.